Skip to content

Management of Type 1 Supracondylar Humeral Fractures

Trauma | Elbow Fracture

This study compares the clinical outcomes of treating pediatric Type 1 supracondylar fracture with a long arm soft cast and no clinical or radiographic follow-up versus the standard treatment in a long arm cast with clinical follow-up.

This is the first multicenter randomized control trial looking at the clinical effectiveness, safety and parental satisfaction of managing inherently stable Type I supracondylar fractures without clinical or radiological follow-up. If found to be safe; children can be managed effectively without in-person follow-up, freeing clinic appointments to children on the waiting list and in these COVID times avoiding unnecessary contacts.

null

Conditions de participation

  • Sexe:

    ALL
  • Âges admissibles:

    3 to 8

Critères de participation

Inclusion Criteria:

- Children 3 to 8 years of age with a diagnosed supracondylar humerus fracture Type 1 (undisplaced).

Exclusion Criteria:

* Children diagnosed with a Type II or III supracondylar fracture or any other elbow injury
* Children who present with neurovascular compromise associated with their fracture
* Children who have been previously diagnosed with a metabolic or structural bone disease that predisposes them to fractures

Diagnostic criteria for a Type I supracondylar fracture will include either:

A) A clear fracture line through the supracondylar region with no displacement or angulation of the distal humerus (including a normal anterior humeral line that intersects the capitellum) OR B) The absence of a clear fracture line but history of an extension injury to the arm AND tenderness at the elbow AND local swelling AND presence of a posterior fat pad on plain radiographs.

Lieu de l'étude

BC Children's Hospital
BC Children's Hospital
Vancouver, British Columbia
Canada

Contactez l'équipe d'étude

Backup Contact

Kishore Mulpuri, FRCSC

Backup Contact

Anthony Cooper, FRCSC

Primary Contact

Harpreet Chhina, PhD

[email protected]
Backup Contact

Paul Enarson, MD, PhD, FRCPC

Backup Contact

Anthony Cooper, FRCSC

[email protected]
Étude parrainée par
University of British Columbia
Participants recherchés
Plus d'informations
ID de l'étude: NCT04642807